ErinHaagBreeseMDPhD

PubMed

• 2 citations
  The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy ...
  Jeremy D Rubinstein, Erin H Breese, M Christa Krupski, Maureen M O'Brien, Christopher E Dandoy, Ben Mizukawa, Ruby Khoury, Robin E Norris, Stella M Davies, Christine L...> ;Transplantation and Cellular Therapy. 2023 May 1
• 14 citations
  Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
  Laurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, Sung K Chiu, Vincent Kuek, Denise Anderson, Grace-Alyssa Chua, Sajla Singh, Joyce Oommen, Emanuela Ferrari, ...> ;Leukemia. 2023 Jan 1
• 12 citations
  Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
  Rachael R. Schulte, Ashley Hinson, Van Huynh, Erin H. Breese, Joanna Pierro, Seth J. Rotz, Benjamin A. Mixon, Jennifer L. McNeer, Michael J. Burke, Etan Orgel> ;Cancer Medicine. 2021 Sep 16
• 3 citations
  Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective
  Jeremy D. Rubinstein, Rachana Shah, Erin H. Breese, Karen Burns, Jennifer Mangino, Robin E. Norris, Lynn Lee, Benjamin Mizukawa, Maureen M. O'Brien, Christine L Philli...> ;Pediatric Blood & Cancer. 2021 May 21
• 8 citations
  Acute Leukemia in Infants
  Azada Ibrahimova, Lauren Pommert, Erin H. Breese> ;Current Oncology Reports. 2021 Feb 12
• 12 citations
  Inotuzumab ozogamicin in infants and young children with relapsed or refractory acute lymphoblastic leukaemia: a case series
  Erica Brivio, Christophe F Chantrain, Tanja A. Gruber, Adriana Thano, Fanny Rialland, Audrey Contet, Sarah Elitzur, Luciano Dalla-Pozza, Krisztián Miklós Kállay, Chi K...> ;British Journal of Haematology. 2021 Feb 2
• 7 citations
  Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
  Erin H. Breese, Christa Krupski, Adam S. Nelson, John P. Perentesis, Christine L Phillips> ;Journal of Pediatric Hematology/oncology. 2021 May 1
• 2 citations
  Capped antithrombin III dosing is cost effective in the management of asparaginase‐associated thrombosis
  Jennifer Young, Jaclyn Sawyer, Meredith Jenkins, Maureen M. O'Brien, Lori Luchtman-Jones, Erin H. Breese> ;Pediatric Blood & Cancer. 2019 Jun 1
• 2 citations
  Experiences of a Multidisciplinary Genomic Tumor Board Interpreting Risk for Underlying Germline Variants in Tumor-Only Sequencing Results
  Kristen P. Fishler, Erin H. Breese, Lauren Walters-Sen, Michelle L. McGowan> ;JCO Precision Oncology. 2019 Apr 11
• 25 citations
  Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
  Arun Gurunathan, Alexander A. Boucher, Melissa Mark, Kristina M. Prus, Maureen M. O'Brien, Erin H. Breese, Benjamin Mizukawa, Michael J. Absalon, Adam S. Nelson, Micha...> ;Pediatric Blood & Cancer. 2018 Dec 1
• 19 citations
  MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.
  Corina Schneidawind, Johan Jeong, Dominik Schneidawind, In-Suk Kim, Jesus Duque-Afonso, Stephen H.K. Wong, Masayuki Iwasaki, Erin H. Breese, James L. Zehnder, Matthew ...> ;Blood Advances. 2018 Apr 24
• 10 citations
  Viral surveillance using PCR during treatment of AML and ALL.
  Stephanie B. Dixon, Adam Lane, Maureen M. O'Brien, Karen Burns, Jennifer Mangino, Erin H. Breese, Michael J. Absalon, John P. Perentesis, Christine L Phillips> ;Pediatric Blood & Cancer. 2018 Jan 1
• 45 citations
  MLL leukemia induction by genome editing of human CD34+ hematopoietic cells
  Corina Buechele, Erin H. Breese, Dominik Schneidawind, Chiou-Hong Lin, Johan Jeong, Jesus Duque-Afonso, Stephen H.K. Wong, Kevin S. Smith, Robert S. Negrin, Matthew H....> ;Blood. 2015 Oct 1
• 17 citations
  Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.
  Erin H. Breese, Corina Buechele, Catherine Dawson, Michael L. Cleary, Matthew H. Porteus> ;Plos One. 2015 Sep 9
• 3 citations
  SIMPL enhancement of tumor necrosis factor-α dependent p65-MED1 complex formation is required for mammalian hematopoietic stem and progenitor cell function.
  Weina Zhao, Erin Haag Breese, Allison Bowers, Jonathan Hoggatt, Louis M. Pelus, Hal E. Broxmeyer, Mark G. Goebl, Maureen A. Harrington> ;Plos One. 2013 Apr 22
• 32 citations
  Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Early Treatment is Beneficial
  Erin Haag Breese, J. Dalmau, Vanda A. Lennon, Metha Apiwattanakul, Deborah K. Sokol> ;Pediatric Neurology. 2010 Mar 1
• 9 citations
  The disordered amino-terminus of SIMPL interacts with members of the 70-kDa heat-shock protein family
  Erin Haag Breese, Vladimir N. Uversky, Millie M. Georgiadis, Maureen A. Harrington> ;DNA and Cell Biology. 2006 Dec 1
• 28 citations
  Tumor Necrosis Factor Alpha Induction of NF-κB Requires the Novel Coactivator SIMPL
  Hyung-Joo Kwon, Erin Haag Breese, Eva Vig-Varga, Yong Luo, Younghee Lee, Mark G. Goebl, Maureen A. Harrington> ;Molecular and Cellular Biology. 2004 Nov 1
• Join now to see all

Abstracts/Posters

• V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia
  Erin H. Breese, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Predicting Drug Response and Novel Therapeutic Candidates Using Signatures of Molecular Alterations in Hematologic Malignancies 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• In Vitro Approach for the Identification of Exceptional Responders in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018